Synakiewicz Anna, Stachowicz-Stencel Teresa, Renke Joanna, Lange Magdalena, Adamkiewicz-Drożyńska Elżbieta, Balcerska Anna
Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Gdańsk, Poland.
Med Wieku Rozwoj. 2013 Apr-Jun;17(2):126-9.
Systemic mastocytosis is a myeloproliferative disorder characterized by growth and accumulation of abnormal mast cells in one or more organs. The symptoms of the disease are due both to the mast cells infiltrating the organs and to the action of its degranulation products. Over 85% of adult patients exhibit point mutations of KIT at position 816 (D816V). Systemic mastocytosis is rare in both adults and children, so treatment is highly individualized; therapy and further treatment is adjusted to each patient's needs. The aim of this study was to present the case of a 14-year old female with systemic mastocytosis and the problems with her treatment. Multidisciplinary management is recommended in systemic mastocytosis.
系统性肥大细胞增多症是一种骨髓增殖性疾病,其特征是异常肥大细胞在一个或多个器官中生长和积聚。该疾病的症状既归因于肥大细胞浸润器官,也归因于其脱颗粒产物的作用。超过85%的成年患者在第816位(D816V)表现出KIT基因点突变。系统性肥大细胞增多症在成人和儿童中均罕见,因此治疗高度个体化;治疗及后续治疗会根据每位患者的需求进行调整。本研究的目的是介绍一名14岁患有系统性肥大细胞增多症的女性病例及其治疗中出现的问题。系统性肥大细胞增多症推荐采用多学科管理。